Sirius Genomics Announces Change in Leadership

11-Dec-2009 - Canada

Sirius Genomics announced that Chris Wagner has been appointed President and Chief Executive Officer, replacing Dr.Brad Popovich. Dr. Popovich will continue as member of Sirius Genomics Board and will continue to assist Mr. Wagner and the Company with the provision of strategic advice and support.

Chris Wagnerhas over 17 years of experience in marketing, sales and business development. Since 2007, Mr. Wagner was Vice President of Business Development at Sirius Genomics. Previously, Mr. Wagner was with Aspreva Pharmaceuticals as the Vice President of Marketing and Vice President of Business Development. Prior to Aspreva, Mr. Wagner was with Eli Lilly as an international service employee working in Europe, North America and Asia with positions based inToronto, Indianapolis and Boston. Mr. Wagner holds a BSc in Organic Chemistry from theUniversity of British Columbia.

Other news from the department people

Most read news

More news from our other portals